We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Editas Medicine
EDIT
$399M
| $164K | ﹤0.01% |
13,397
+291
| +2% | +$4.53K |
|
|
RNAM
1452
DELISTED
Avidity Biosciences
RNAM
| $164K | ﹤0.01% |
+10,032
| New | +$192K |
|
1453
Wolverine World Wide
WWW
$1.54B
| $164K | ﹤0.01% |
10,677
-629
| -6% | -$13K |
|
1454
Acadia Realty Trust
AKR
$2.99B
| $163K | ﹤0.01% |
12,856
-332
| -3% | -$5.32K |
|
|
ARI
1455
Apollo Commercial Real Estate
ARI
$887M
| $158K | ﹤0.01% |
19,033
-567
| -3% | -$6.5K |
|
|
BDN
1456
Brandywine Realty Trust
BDN
$551M
| $158K | ﹤0.01% |
23,384
-602
| -3% | -$5.14K |
|
1457
Coherus Oncology
CHRS
$217M
| $158K | ﹤0.01% |
16,412
+264
| +2% | +$2.67K |
|
1458
Tronox
TROX
$995M
| $158K | ﹤0.01% |
12,899
-246
| -2% | -$3.65K |
|
|
TWO
1459
Two Harbors Investment
TWO
$1.27B
| $157K | ﹤0.01% |
11,867
-305
| -3% | -$5.92K |
|
1460
Sana Biotechnology
SANA
$885M
| $155K | ﹤0.01% |
25,815
+1,045
| +4% | +$7.54K |
|
|
CANO
1461
DELISTED
Cano Health, Inc.
CANO
| $155K | ﹤0.01% |
178
-4
| -2% | -$2.51K |
|
|
PR
1462
Permian Resources
PR
$17.9B
| $153K | ﹤0.01% |
22,681
-431
| -2% | -$2.98K |
|
1463
DNOW Inc
DNOW
$2.63B
| $152K | ﹤0.01% |
15,178
-388
| -2% | -$4.19K |
|
1464
Global Net Lease
GNL
$1.87B
| $152K | ﹤0.01% |
14,312
-367
| -3% | -$5.11K |
|
1465
MannKind Corp
MNKD
$1.28B
| $152K | ﹤0.01% |
49,084
+1,454
| +3% | +$5.48K |
|
1466
Knowles
KN
$3.22B
| $151K | ﹤0.01% |
12,374
-325
| -3% | -$5.21K |
|
1467
Frontline
FRO
$8.75B
| $150K | ﹤0.01% |
13,749
-261
| -2% | -$2.86K |
|
1468
NeoGenomics
NEO
$1.81B
| $149K | ﹤0.01% |
17,300
-2,270
| -12% | -$22.5K |
|
1469
Capitol Federal Financial
CFFN
$1.08B
| $148K | ﹤0.01% |
17,851
-461
| -3% | -$4.29K |
|
|
PMT
1470
PennyMac Mortgage Investment
PMT
$849M
| $147K | ﹤0.01% |
12,456
-516
| -4% | -$7.54K |
|
1471
Anavex Life Sciences
AVXL
$222M
| $146K | ﹤0.01% |
14,180
+486
| +4% | +$5.13K |
|
1472
FuelCell Energy
FCEL
$1.7B
| $146K | ﹤0.01% |
1,431
+47
| +3% | +$5.63K |
|
|
NGM
1473
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $145K | ﹤0.01% |
11,138
+562
| +5% | +$8.51K |
|
1474
Payoneer
PAYO
$2.41B
| $144K | ﹤0.01% |
23,860
-462
| -2% | -$2.68K |
|
|
ME
1475
DELISTED
23andMe Holding Co
ME
| $144K | ﹤0.01% |
2,516
+552
| +28% | +$36.1K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.